MedPath

Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder

Phase 2
Completed
Conditions
ADHD
Registration Number
NCT00364702
Lead Sponsor
Shaare Zedek Medical Center
Brief Summary

Using a virtual reality program in screening and treatment of ADHD.

Detailed Description

Virtual Reality is a novel program designed to imitate a real classroom environment including various distractions. It includes a head monitor to track eye movements Children aged 10-20 years with ADHD will use the program with and without methylphenidate(1 mg/kg). Their results will be compared to a control group.

Parental consent will be obtained.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria

Clinical diagnosis of ADHD-DSM4 criteria AGE 10-20 YEARS normal neurological examination IQ>80

Exclusion Criteria

ABNORMAL NEUROLOGICAL STATUS

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Virtual Reality program test results
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Shaari Zedek Pediatric Neurology Unit

🇮🇱

Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath